# Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure

> **NCT02592499** · NA · UNKNOWN · sponsor: **Vastra Gotaland Region** · enrollment: 80 (estimated)

## Conditions studied

- End-stage Heart Failure

## Interventions

- **DEVICE:** HM III
- **OTHER:** OMM, optimal medical management

## Key facts

- **NCT ID:** NCT02592499
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2023-12
- **Final completion:** 2025-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-04-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02592499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02592499, "Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02592499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*